Alzheimer's disease

Double Helix Deception: The Return of Genetic Testing Scams in Medicare Fraud

Retrieved on: 
Thursday, May 2, 2024
Alzheimer's disease, Roger Hawkins (drummer), Cancer, Senior Medicare Patrols, Genetic testing, Confusion, DNA, Caregiver, Medicare, SMP, SMPS, Fraud, Pharmaceutical industry

WASHINGTON, May 2, 2024 /PRNewswire/ -- One of the biggest scams targeting Medicare beneficiaries in the last decade has been the genetic testing scam.

Key Points: 
  • WASHINGTON, May 2, 2024 /PRNewswire/ -- One of the biggest scams targeting Medicare beneficiaries in the last decade has been the genetic testing scam.
  • Recently, the Senior Medicare Patrol (SMP) has seen an increase in genetic testing complaints.
  • Across the nation, genetic testing company representatives are offering "free" genetic tests, also referred to as DNA screenings, cancer screenings, and hereditary testing, in exchange for the beneficiaries' Medicare numbers.
  • The SMP has also received reports of genetic testing claims on Medicare statements when the beneficiaries never received any contact about genetic testing.

American College of Lifestyle Medicine Celebrates 20th Anniversary and Announces Speakers, Presenting Sponsor for 2024 Annual CME/CE-Accredited Conference Oct. 27-30

Retrieved on: 
Thursday, May 2, 2024
Consensus, Online, Alzheimer's disease, MAS, Planning committee, Therapy, MPA, CME, American College, DOS, Certification, LM, Health, ACLM, Consensus decision-making, Conference, Person-centered therapy, Research, Loma Linda University, Nursing, MPH, Food, FACPM, RN, ACO, Medicine, Conditional sentence, Practitioner, Prometric, Social, MBA, Student, Human, FACP, Pharmacist, Livestreaming

ST. LOUIS, May 2, 2024 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine (ACLM) today announced the keynote speaker lineup for its 2024 Lifestyle Medicine Annual Conference, set for October 27-30, in person at the Rosen Shingle Creek Resort in Orlando, Fla., with virtual registration also available. The hybrid event will showcase how lifestyle medicine is changing the paradigm of medical education and clinical practice to restore health for those living with chronic disease. Presenting sponsor for the event is Lore Health, a leading lifestyle-medicine focused accountable care organization (ACO).

Key Points: 
  • The American College of Lifestyle Medicine (ACLM) today announced the keynote speaker lineup for its 2024 Lifestyle Medicine Annual Conference, set for October 27-30, in person at the Rosen Shingle Creek Resort, Orlando, Fla., as well as virtually.
  • ST. LOUIS, May 2, 2024 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine (ACLM) today announced the keynote speaker lineup for its 2024 Lifestyle Medicine Annual Conference, set for October 27-30, in person at the Rosen Shingle Creek Resort in Orlando, Fla., with virtual registration also available.
  • Concurrent sessions for the in-person event will be offered in four tracks : Application of Lifestyle Medicine; Allied Health Providers in Lifestyle Medicine; Healthcare Transformation Through Lifestyle Medicine; and Current Issues in Healthcare.
  • For more information about the conference or to register, visit Lifestyle Medicine Conference 2024 - American College of Lifestyle Medicine .

NeuroSense Announces First Quarter 2024 Business Update

Retrieved on: 
Thursday, May 2, 2024
FDA, American Academy, Hospital, AFL, Research, Alzheimer's disease, AAN, ALS, Exosome, Biomarker, Quality of life, Massachusetts General Hospital, Pharmaceutical industry

CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.

Key Points: 
  • CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
  • In addition, our PARADIGM results received significant validation when they were accepted as late breaking data at the AAN conference," stated NeuroSense CEO Alon Ben-Noon.
  • "As we proceed through the second quarter, we anticipate further collaborations as well as to schedule an end of Phase 2 study with FDA in order to continue this important research into a Phase 3 clinical trial.
  • We look forward to providing additional new data from the PARADIGM trial," concluded Mr. Ben-Noon.

MCRA Supports Darmiyan with FDA Approval for BrainSee Device

Retrieved on: 
Thursday, May 2, 2024
Alzheimer's disease, FDA, Brain, MCI, Policy, Food, Montreal Cognitive Assessment, De novo, Artificial intelligence, Digital, Science, Digital health, MCRA, MRI, Marketing, Contract research organization, Pharmaceutical industry

MCRA announces its role in the successful granting of Darmiyan's De Novo request for BrainSee by the FDA.

Key Points: 
  • MCRA announces its role in the successful granting of Darmiyan's De Novo request for BrainSee by the FDA.
  • Darmiyan retained MCRA in 2021 for its broad and deep experience in Neurology, Digital Health, and Artificial Intelligence (AI).
  • John Doucet, Vice President, Neurology Regulatory Affairs – Neuromodulation and Evolving Technologies at MCRA states, "We are proud to have worked closely with Darmiyan to achieve both Breakthrough Device Designation and marketing authorization from the FDA for BrainSee.
  • The FDA Breakthrough Device Designation for BrainSee was a critical foundation for FDA collaborations during development, review, and granting of the De Novo request.

Benchmark Senior Living at Split Rock Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Straight Year

Retrieved on: 
Wednesday, May 1, 2024
Alzheimer's disease, Housekeeping, Safety, News, Heart, Mind, Communication, Research, Transport, Dementia, Environment, Food, Empathy, Amnesia, Quality of life, Senior living, Nursing

SHELTON, Conn., May 1, 2024 /PRNewswire-PRWeb/ -- Benchmark Senior Living at Split Rock, an assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World Report's third annual Best Senior Living ratings published last week, the community was selected following a comprehensive resident and family member survey. Split Rock is the only senior living community in Shelton to have earned this prestigious award.

Key Points: 
  • In U.S. News & World Report's third annual Best Senior Living ratings published last week, the community was selected following a comprehensive resident and family member survey.
  • Split Rock is the only senior living community in Shelton to have earned this prestigious award.
  • -Dan Hennessey, executive director, Benchmark Senior Living at Split Rock
    Split Rock earned "Best" status by achieving the highest possible rating for assisted living.
  • For more information about Benchmark at Split Rock, click here or go to its U.S. News profile at https://health.usnews.com/best-senior-living/benchmark-at-Split Rock-1877 .

The Village at Buckland Court Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Straight Year

Retrieved on: 
Wednesday, May 1, 2024
Alzheimer's disease, Housekeeping, Safety, News, Heart, Mind, Communication, Research, Transport, Dementia, Environment, Food, Empathy, Amnesia, Quality of life, MSW, Senior living, Village, Nursing

SOUTH WINDSOR, Conn., May 1, 2024 /PRNewswire-PRWeb/ -- The Village at Buckland Court, a Benchmark assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World Report's third annual Best Senior Living ratings published last week, the community was selected following a comprehensive resident and family member survey. The Village is the only senior living community in the greater Windsor and South Windsor areas to have earned this prestigious award.

Key Points: 
  • In U.S. News & World Report's third annual Best Senior Living ratings published last week, the community was selected following a comprehensive resident and family member survey.
  • The Village is the only senior living community in the greater Windsor and South Windsor areas to have earned this prestigious award.
  • -Allyson Sweeney, MSW, executive director, The Village at Buckland Court
    The Village earned "Best" status by achieving the highest possible rating for assisted living.
  • For more information about The Village at Buckland Court, click here or go to its U.S. News profile at https://health.usnews.com/best-senior-living/benchmark-at-The Village-1877 .

Benchmark Senior Living at Plymouth Crossings Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Straight Year

Retrieved on: 
Wednesday, May 1, 2024
Alzheimer's disease, Housekeeping, Safety, News, Heart, Mind, Communication, Research, Transport, Dementia, Environment, Food, Empathy, Amnesia, Quality of life, Senior living, Nursing

PLYMOUTH, Mass., May 1, 2024 /PRNewswire-PRWeb/ -- Benchmark Senior Living at Plymouth Crossings, an assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year. In U.S. News & World Report's third annual Best Senior Living ratings published last week, the community was selected following a comprehensive resident and family member survey. Plymouth Crossings is the only community in Southern Plymouth County to have earned both prestigious awards.

Key Points: 
  • PLYMOUTH, Mass., May 1, 2024 /PRNewswire-PRWeb/ -- Benchmark Senior Living at Plymouth Crossings , an assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year.
  • In U.S. News & World Report's third annual Best Senior Living ratings published last week, the community was selected following a comprehensive resident and family member survey.
  • -Ashley Roberts, executive director, Benchmark Senior Living at Plymouth Crossings
    Plymouth Crossings earned "Best" status by achieving the highest possible rating for both assisted living and memory care.
  • For more information about Benchmark Senior Living at Plymouth Crossings, click here or go to its U.S. News profile at https://health.usnews.com/best-senior-living/benchmark-senior-living-at-... .

Ayana Bio Awarded National Institutes of Health Grant to Harness Neuroprotective Benefits from Plant Cell-Cultivated Saffron

Retrieved on: 
Wednesday, May 1, 2024
Climate change, Bangladesh Technical Education Board, Huntington's disease, Saffron, NIH, Health, Flower, Weight loss, Research, Taste, Depression, Stainless steel, Plant, Alzheimer's disease, Alternative medicine, NCCIH, Anxiety, Spice

BOSTON, May 1, 2024 /PRNewswire/ -- Ayana Bio, the plant cell technology company dedicated to creating sustainable bioactives for consumer products, has received a grant from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to support Ayana Bio's research into the production of saffron's neuroprotective bioactives through plant cell cultivation.  

Key Points: 
  • BOSTON, May 1, 2024 /PRNewswire/ -- Ayana Bio , the plant cell technology company dedicated to creating sustainable bioactives for consumer products, has received a grant from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to support Ayana Bio's research into the production of saffron's neuroprotective bioactives through plant cell cultivation.
  • Saffron's neurological effects are also proven to aid in weight loss by increasing satiety , making it a powerful health ingredient with interconnected benefits.
  • The $300 thousand NIH grant will fund Ayana Bio's research to identify which complex of saffron bioactives can consistently demonstrate the highest neuroprotective benefits, specifically for Huntington's disease.
  • "Today's grant from the NIH is a validation of plant cell cultivation's ability to unlock botanicals like saffron's powerful benefits and improve health outcomes."

Korea Ginseng Corporation Held a Dedicated International Seminar at the International Conference on the Science of Botanicals (ICSB) About Korean Red Ginseng in the United States

Retrieved on: 
Tuesday, April 30, 2024
Science, FDA, Food, Deficit spending, Food safety, Brain, Inflammation, KGC, Conference, China Medical University, Pharmacy, National Science Foundation, Konkuk University, Chili pepper, Safety, NIH, Hospital, Health, Research, Taste, USDA, Fatigue, Alzheimer's disease, Risk assessment, Medical school, GRAS, University, NSF, Patient, Immunity, Dietary supplement

CERRITOS, Calif., April 30, 2024 /PRNewswire/ -- Korea Ginseng Corp. US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB) hosted by the National Center for Natural Products Research (NCNPR). The conference is held annually at the Oxford Conference Center in Mississippi to bring together international leaders in the research, development, testing, regulation, and commercialization of botanical ingredients used for human health. From April 15th to 18th, approximately 400 attendees including government officials from the U.S. Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), the National Science Foundation (NSF), and the National Institute of Health (NIH), university professors, researchers, and buyers partook in ICSB this year. 

Key Points: 
  • US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB) hosted by the National Center for Natural Products Research (NCNPR).
  • Through the seminars, attendees were able to gain insight into the safety and the significant benefits of Korean red ginseng.
  • The "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights" seminar consisted of presentations of scientifically proven research on the various efficacies of Korean red ginseng, where researchers from Korea, the United States, and Taiwan presented their results.
  • The company, Korean Ginseng Corporation, has conducted animal toxicity testing and numerous clinical trials with their red ginseng extract.

Rippl acquires AI healthcare startup Kinto to accelerate building nation's most advanced tech-enabled dementia care platform

Retrieved on: 
Tuesday, April 30, 2024
Bangladesh Technical Education Board, AI, Partnership, Dementia, Alzheimer's disease, Patient, Acquisition, Caregiver, Chung, Multimedia, Architecture, Residential care

SEATTLE, April 30, 2024 /PRNewswire/ -- Today Rippl, a leading dementia-focused specialty care provider, announced it has acquired Kinto, a Boston-based, AI-enabled dementia caregiver support platform. This combination will fuel reaching an exponentially larger group of people living with dementia and their caregivers with human-centered care far beyond traditional bricks-and-mortar models.

Key Points: 
  • This partnership brings together Rippl's proven dementia care model, validated by clinical research including the UCSF Care Ecosystem Study, and Kinto's acclaimed evidence-based, AI-enabled dementia caregiver support and education program.
  • This work includes state-of-the-art Generative AI tools that augment the work of trusted care teams who guide caregivers through their incredibly challenging care journeys.
  • By partnering with Rippl, we can combine, enhance and scale our solutions to become leaders in virtual dementia care."
  • Rippl is now positioned to be the leading player in dementia care with a comprehensive and empathetic model, ethically employing the scaling power of AI," said Chadwell.